Radiopharmaceuticals startup RayzeBio submits IPO pitch, foreshadowing expected post-Labor Day bump in biotech listings

A Phase III-stage ra­dio­phar­ma­ceu­ti­cals biotech has filed to go pub­lic a lit­tle over a week be­fore bankers and in­dus­try watch­ers ex­pect a slight post-La­bor Day bump in biotech IPO pitch­es. Af­ter hav­ing raised $418 mil­lion pri­vate­ly, the San Diego start­up Rayze­Bio hopes to gain…#sandiego #ryzb #jordansaxe #newyears #unlock

Source: Reuters: Health - August 25, 2023 Category: Consumer Health News Source Type: news